Erratum to: Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 x Brown Norway rats (Age DOI: 10.1007/s11357-010-9196-y);Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 x Brown Norway rats

Age

Volumn 33, Issue 2, 2011, Pages 167-183

  Carter, Christy S ^a   Giovaninni, Silvia ^a,b   Seo, Dong Oh ^a   Dupree, Jameson ^a   Morgan, Drake ^a   Chung, Hae Young ^c   Lees, Hazel ^a   Daniels, Michael ^d   Hubbard, Gene B ^e   Lee, Shuko ^f   Ikeno, Yuji ^e,f   Foster, Thomas C ^a   Buford, Thomas W ^a   Marzetti, Emanuele ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c Pusan National University   (South Korea)

^d University of Florida   (United States)

^e University of Texas Health Science Center   (United States)

^f SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Age related adiposity; Body composition; Muscle quality; Physical function; Renin angiotensin system; Sarcopenia

Indexed keywords

CASPASE; ENALAPRIL; LOSARTAN; PLACEBO;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY TEMPERATURE; CONTROLLED STUDY; DNA FRAGMENTATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; FOOD INTAKE; GENETIC ANALYSIS; GRIP STRENGTH; MALE; MITOCHONDRION; MUSCLE CELL; MUSCLE QUALITY; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TUMOR GROWTH;

EID: 79959549510     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9243-3     Document Type: Erratum

References (47)

1. Bahi L, Koulmann N, Sanchez H, Momken I, Veksler V, Bigard AX et al (2004) Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol 96:59-64
2. Basso N, Cini R, Pietrelli A, Ferder L, Terragno NA, Inserra F (2007) Protective effect of long-term angiotensin II inhibition. Am J Physiol Heart Circ Physiol 293:H1351-H1358 (Pubitemid 47367173)
3. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M et al (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma-modulating activity. Hypertension 43:993-1002 (Pubitemid 38579904)
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Carter CS, Sonntag WE, Onder G, Pahor M (2002) Physical performance and longevity in aged rats. J Gerontol A Biol Sci Med Sci 57:B193-B197 (Pubitemid 34464962)
6. Carter CS, Cesari M, Ambrosius WT, Hu N, Diz D, Oden S et al (2004) Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats. J Gerontol A Biol Sci Med Sci 59:416-423 (Pubitemid 38649931)
7. Carter CS, Onder G, Kritchevsky SB, Pahor M (2005) Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. J Gerontol A Biol Sci Med Sci 60:437-1446
8. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205-219 (Pubitemid 38167313)
9. de Cavanagh EM, Inserra F, Ferder M, Ferder L (2007) From mitochondria to disease: role of the renin-angiotensin system. Am J Nephrol 27:545-553 (Pubitemid 350014941)
10. de Grey AD (2007) The case for prioritizing research on lateonset life-extension interventions in mammals. Rejuvenation Res 10:257-259
11. Feng X, Luo Z, Ma L, Ma S, Yang D, Zhao Z et al (2010) Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR delta/AMPK pathway. J Cell Mol Med (in press)
12. Foianini KR, Steen MS, Kinnick TR, Schmit MB, Youngblood EB, Henriksen EJ (2000) Effects of exercise training and ACE inhibition on insulin action in rat skeletal muscle. J Appl Physiol 89:687-694 (Pubitemid 30637119)
13. Gabriely I, Barzilai N (2003) Surgical removal of visceral adipose tissue: effects on insulin action. Curr Diab Rep 3:201-206 (Pubitemid 38906773)
14. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS et al (1998) Elite endurance athletes and the ACE I allele - the role of genes in athletic performance. Hum Genet 103:48-50 (Pubitemid 28398384)
15. Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB et al (2001) Attenuation of skeletal muscle and strength in the elderly: the health ABC Study. J Appl Physiol 90:2157-2165
16. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV et al (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059-1064 (Pubitemid 44727214)
17. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49:M85-M94 (Pubitemid 24100267)
18. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392-395
19. He H, Yang D, Ma L, Luo Z, Ma S, Feng X et al (2010) Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. Hypertension 55:869-879
20. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776
21. Henriksen EJ, Jacob S (2003) Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J Cell Physiol 196:171-179 (Pubitemid 36676455)
22. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ (1997) Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 272:19022-19026 (Pubitemid 27318258)
23. Ikeno Y, Bronson RT, Hubbard GB, Lee S, Bartke A (2003) Delayed occurrence of fatal neoplastic diseases in Ames dwarf mice: correlation to extended longevity. J Gerontol A Biol Sci Med Sci 58:291-296 (Pubitemid 36397045)
24. Iwasaki K, Gleiser CA, Masoro EJ, McMahan CA, Seo EJ, Yu BP (1988) The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol 43:B5-B12 (Pubitemid 18029928)
25. Jeong SY, Seol DW (2008) The role of mitochondria in apoptosis. BMB Rep 41:11-22
26. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
27. Maeda H, Gleiser CA, Masoro EJ, Murata I, McMahan CA, Yu BP (1985) Nutritional influences on aging of Fischer 344 rats: II. Pathology. J Gerontol 40:671-688
28. Marzetti E, Groban L, Wohlgemuth SE, Lees HA, Lin M, Jobe H et al (2008a) Effects of short-term GH supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats. Am J Physiol Regul Integr Comp Physiol 294:R558-R567 (Pubitemid 351213762)
29. Marzetti E, Wohlgemuth SE, Lees HA, Chung HY, Giovannini S, Leeuwenburgh C (2008b) Age-related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle. Mech Ageing Dev 129:542-549
30. Marzetti E, Carter CS, Wohlgemuth SE, Lees HA, Giovannini S, Anderson B et al (2009a) Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech Ageing Dev 130:272-280
31. Marzetti E, Hwang JC, Lees HA, Wohlgemuth SE, Dupont- Versteegden EE, Carter CS et al (2009b) Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta 1800:235-244
32. Newman AB, Yanez D, Harris T, Duxbury A, Enright PL, Fried LP (2001) Weight change in old age and its association with mortality. J Am Geriatr Soc 49:1309-1318 (Pubitemid 33015207)
33. Newman AB, Haggerty CL, Goodpaster B, Harris T, Kritchevsky S, Nevitt M et al (2003) Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc 51:323-330 (Pubitemid 36348893)
34. Olshansky SJ, Goldman DP, Zheng Y, Rowe JW (2009) Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q 87:842-862
35. Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J et al (2002) Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 359:926-930 (Pubitemid 34246382)
36. Rae MJ, Butler RN, Campisi J, de Grey AD, Finch CE, Gough M et al (2010) The demographic and biomedical case for late-life interventions in aging. Sci Transl Med 2:40cm21
37. Rice KM, Linderman JK, Kinnard RS, Blough ER (2005) The Fischer 344/NNiaHSd X Brown Norway/BiNia is a better model of sarcopenia than the Fischer 344/NNiaHSd: a comparative analysis of muscle mass and contractile properties in aging male rat models. Biogerontology 6:335-343 (Pubitemid 43193663)
38. Santos EL, de Picoli SK, da Silva ED, Batista EC, Martins PJF, D'Almeida V et al (2009) Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats. Biochem Pharmacol 78:951-958
39. Scarpace PJ, Zhang Y (2009) Leptin resistance: a predisposing factor for diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 296:R493-R500
40. Schwartz RS (1998) Obesity in the elderly. In: Bray GA, Bouchard C, James WPT (eds) Handbook of obesity. Marcel Dekker, New York, pp 103-114
41. Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC (2010) Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol 11:627-636
42. Song W, Kwak HB, Lawler JM (2006) Exercise training attenuates age-induced changes in apoptotic signaling in rat skeletal muscle. Antioxid Redox Signal 8:517-528 (Pubitemid 43741321)
43. Visser M, Langlois J, Guralnik JM, Cauley JA, Kronmal RA, Robbins J et al (1998) High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr 68:584-590 (Pubitemid 28402380)
44. Weisinger RS, Begg DP, Jois M (2009a) Antagonists of the renin-angiotensin system and the prevention of obesity. Curr Opin Investig Drugs 10:1069-1077
45. Weisinger RS, Stanley TK, Begg DP, Weisinger HS, Spark KJ, Jois M (2009b) Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6 J mice maintained on a high fat diet. Physiol Behav 98:192-197
46. Yu BP, Masoro EJ, Murata I, Bertrand HA, Lynd FT (1982) Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J Gerontol 37:130-141
47. Zhang Y, Scarpace PJ (2006) The role of leptin in leptin resistance and obesity. Physiol Behav 88:249-256